Positron Emission Tomography in Breast Cancer: 18f- FDG and Other Radiopharmaceuticals

European Journal of Hybrid Imaging
doi 10.1186/s41824-018-0039-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

False Positive 18f-FDG Uptake in Mediastinal Lymph Nodes Detected With Positron Emission Tomography in Breast Cancer: A Case Report

Case Reports in Medicine
Medicine
2013English

IgG4-associated Multifocal Systemic Fibrosis Detected by Cancer Screening With 18f-FDG Positron Emission Tomography/Computed Tomography

RADIOISOTOPES
2010English

Pulmonary Aspergillosis: An Alternative Diagnosis to Lung Cancer After Positive [18F]FDG Positron Emission Tomography

Thorax
PulmonaryRespiratory Medicine
2011English

Positron-Emission Tomography Imaging in Breast Cancer

Oncology & Hematology Review (US)
2011English

Liver and Bone Metastases From Breast Cancer: Eovist® Magnetic Resonance and Diffusion Weighted Imaging, 18f-FDG Positron Emission/Computed Tomography

Digestive and Liver Disease
HepatologyGastroenterology
2016English

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

18f-Fluorodeoxyglucose Positron-Emission Tomography-Computed Tomography to Diagnose Recurrent Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

18f-Fluoroestradiol Positron Emission Tomography Imaging of Activating Estrogen Receptor Alpha Mutations in Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Does 18f-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma?

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy